access your medical records
Home > Research at Avera > Clinical Trials at Avera > Clinical Trials Search Results
The purpose of this study is to assess the efficacy and safety of itacitinib in combination with corticosteroids as first-line treatment for moderate or severe chronic graft-versus-host disease (cGVHD).
© 2022 Avera Health, Sioux Falls, SD. All Rights Reserved.